Cargando…
Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
BACKGROUND: Obesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and im...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196397/ https://www.ncbi.nlm.nih.gov/pubmed/37215211 http://dx.doi.org/10.3389/fnut.2023.1156995 |
_version_ | 1785044344517951488 |
---|---|
author | Borja-Magno, Angélica Guevara-Cruz, Martha Flores-López, Adriana Carrillo-Domínguez, Silvia Granados, Julio Arias, Clorinda Perry, Mary Sears, Barry Bourges, Hector Gómez, F. Enrique |
author_facet | Borja-Magno, Angélica Guevara-Cruz, Martha Flores-López, Adriana Carrillo-Domínguez, Silvia Granados, Julio Arias, Clorinda Perry, Mary Sears, Barry Bourges, Hector Gómez, F. Enrique |
author_sort | Borja-Magno, Angélica |
collection | PubMed |
description | BACKGROUND: Obesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and improve metabolic markers. OBJECTIVE: This study aimed to determine the effect of high-dose omega-3 FA on metabolic and inflammatory markers among patients with obesity and healthy volunteers. METHODS: This prospective study included 12 women with obesity (body mass index [BMI] ≥ 35.0 kg/m(2)) and 12 healthy women (BMI < 24.0 kg/m(2)) who were supplemented with a dose of 4.8 g/day (3.2 g EPA plus 1.6 g DHA) for 3 months followed by no treatment for 1 month. Plasma metabolic and inflammatory markers and levels of mRNA transcripts of CD4(+) T lymphocyte subsets were determined monthly. RESULTS: None of the participants exhibited changes in weight or body composition after study completion. EPA and DHA supplementation improved metabolic (insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], triglyceride [TG]/ high-density lipoprotein [HDL] ratio, TG, and arachidonic acid [AA]/EPA ratio) and tumor necrosis factor-alpha (TNF-α). Moreover, the levels of mRNA transcripts of T CD4(+) lymphocyte subsets (TBX21, IFNG, GATA-3, interleukin [IL]-4, FOXP3, IL-10 IL-6, and TNF-α), were down-regulated during the intervention phase. After 1 month without supplementation, only insulin, HOMA-IR and the mRNA transcripts remained low, whereas all other markers returned to their levels before supplementation. CONCLUSION: Supplementation with high-dose omega-3 FAs could modulate metabolism and inflammation in patients with obesity without weight loss or changes in body composition. However, these modulatory effects were ephemeral and with clear differential effects: short-duration on metabolism and long-lasting on inflammation. |
format | Online Article Text |
id | pubmed-10196397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101963972023-05-20 Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation Borja-Magno, Angélica Guevara-Cruz, Martha Flores-López, Adriana Carrillo-Domínguez, Silvia Granados, Julio Arias, Clorinda Perry, Mary Sears, Barry Bourges, Hector Gómez, F. Enrique Front Nutr Nutrition BACKGROUND: Obesity is complicated by low-grade chronic inflammation characterised by increases in inflammatory proteins and cells in peripheral blood. It has been known that omega-3 fatty acids (FA) like eicosapentaenoic (EPA) and docosahexaenoic (DHA) could modulate the inflammatory process and improve metabolic markers. OBJECTIVE: This study aimed to determine the effect of high-dose omega-3 FA on metabolic and inflammatory markers among patients with obesity and healthy volunteers. METHODS: This prospective study included 12 women with obesity (body mass index [BMI] ≥ 35.0 kg/m(2)) and 12 healthy women (BMI < 24.0 kg/m(2)) who were supplemented with a dose of 4.8 g/day (3.2 g EPA plus 1.6 g DHA) for 3 months followed by no treatment for 1 month. Plasma metabolic and inflammatory markers and levels of mRNA transcripts of CD4(+) T lymphocyte subsets were determined monthly. RESULTS: None of the participants exhibited changes in weight or body composition after study completion. EPA and DHA supplementation improved metabolic (insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], triglyceride [TG]/ high-density lipoprotein [HDL] ratio, TG, and arachidonic acid [AA]/EPA ratio) and tumor necrosis factor-alpha (TNF-α). Moreover, the levels of mRNA transcripts of T CD4(+) lymphocyte subsets (TBX21, IFNG, GATA-3, interleukin [IL]-4, FOXP3, IL-10 IL-6, and TNF-α), were down-regulated during the intervention phase. After 1 month without supplementation, only insulin, HOMA-IR and the mRNA transcripts remained low, whereas all other markers returned to their levels before supplementation. CONCLUSION: Supplementation with high-dose omega-3 FAs could modulate metabolism and inflammation in patients with obesity without weight loss or changes in body composition. However, these modulatory effects were ephemeral and with clear differential effects: short-duration on metabolism and long-lasting on inflammation. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196397/ /pubmed/37215211 http://dx.doi.org/10.3389/fnut.2023.1156995 Text en Copyright © 2023 Borja-Magno, Guevara-Cruz, Flores-López, Carrillo-Domínguez, Granados, Arias, Perry, Sears, Bourges and Gómez. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Borja-Magno, Angélica Guevara-Cruz, Martha Flores-López, Adriana Carrillo-Domínguez, Silvia Granados, Julio Arias, Clorinda Perry, Mary Sears, Barry Bourges, Hector Gómez, F. Enrique Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
title | Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
title_full | Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
title_fullStr | Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
title_full_unstemmed | Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
title_short | Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
title_sort | differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196397/ https://www.ncbi.nlm.nih.gov/pubmed/37215211 http://dx.doi.org/10.3389/fnut.2023.1156995 |
work_keys_str_mv | AT borjamagnoangelica differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT guevaracruzmartha differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT floreslopezadriana differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT carrillodominguezsilvia differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT granadosjulio differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT ariasclorinda differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT perrymary differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT searsbarry differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT bourgeshector differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation AT gomezfenrique differentialeffectsofhighdoseomega3fattyacidsonmetabolismandinflammationinpatientswithobesityeicosapentaenoicanddocosahexaenoicacidsupplementation |